课题基金 / 基金详情

CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM

CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM
表征 GAMMA-SEC 活性无细胞系统
批准号:
6845211
负责人:
DAVID E HOKE
金额:
$4.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-22 至 2005-01-21

项目摘要

项目成果

DAVID E HOKE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(来自申请人摘要):淀粉样蛋白的神经元生成
英文摘要
DESCRIPTION (From the applicant's abstract): The neuronal production of amyloid beta (beta) from the amyloid precursor protein (APP) appears to be a necessary and invarieant step in the progression of Alzheimer's disease (AD). Three genes have been linked to early-onset AD. These genes are presenilin 1 (PS1), presenilin 2 (PS2), and APP itself. Mutations in each of these genes lead to the elevated proteolytic processing of APP into Abeta species that aggregate more readily and form amyloid plaques. The fact that three separate genes implicate Abeta as the causative agent of Alzheimer's disease makes this an important target for theraputic intervention. One way to create therapies for AD is to block the proteases that generate Abeta. These proteases have not been unidentified but the activities that create Abeta are termed beta and gamma secretase. The role of gamma secretase is especially important in the progression of AD since this activity can produce more or less aggregating forms of Abeta. It is the aim of this proposed study to characterize the role of PS1 in gamma secretase activity, identifying the subcellular localization of gamma secretase activity, and lastly to identity the gamma secretases. This will be accomplished through biochemical manipulation of cell extracts and monitoring gamma secretase activity in an in vitro assay. The identification of the protease(s) involved in producing abeta at the gamma secretase site will drastically further knowledge of the molecular mechanisms underlying AD and improve chances of creating theraputic inhibitors that slow or stop the progression of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM
  • 批准号:
    6845212
  • 项目类别:
  • 资助金额:
    $0.55万
  • 财政年份:
    2002
  • 负责人:
    DAVID E HOKE
  • 依托单位:
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM
  • 批准号:
    6627913
  • 项目类别:
  • 资助金额:
    $4.09万
  • 财政年份:
    2002
  • 负责人:
    DAVID E HOKE
  • 依托单位:
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM
  • 批准号:
    6696998
  • 项目类别:
  • 资助金额:
    $0.55万
  • 财政年份:
    2002
  • 负责人:
    DAVID E HOKE
  • 依托单位:
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM
  • 批准号:
    6497169
  • 项目类别:
  • 资助金额:
    $3.28万
  • 财政年份:
    2002
  • 负责人:
    DAVID E HOKE
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究